JPRN-UMIN000006987
Recruiting
未知
A prospective study to evaluate the efficacy and safety of pregabalin for triweekly abraxane-induced peripheral neuralgia - Pregabalin for abraxane-induced peripheral neuralgia
Kinki University Faculty of Medicine0 sites30 target enrollmentDecember 29, 2011
ConditionsBreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Kinki University Faculty of Medicine
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Contraindication to abraxane and pregabalin 2\. Creatinine clearance less than 30mL/min 3\. With previous history of pregabalin administration 4\. With unstable dosage of antidepressant drugs at 3 weeks of registration 5\. With serious drug allergy 6\. With severe complications 7\. Pregnant or nursing women 8\. With peripheral neuropathy caused by other drugs 9\. Determination as contraindication by doctors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective study to evaluate the efficacy and safety of a new knife in endoscopic treatment for gastric neoplasmNeoplasmsKCT0005164Asan Medical Center100
Completed
Phase 2
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastasescastration-resistant prostate cancer with bone metastasesJPRN-UMIN000023897ational Hospital Organization Saitama Hospital20
Not yet recruiting
Not Applicable
effect of alpha blockers in benign prostatic hyperplasiaHealth Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsCTRI/2021/04/033122DR I C VIGNESH RAJA
Active, not recruiting
Phase 2
A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.Colorectal CancerJPRN-jRCTs071190003Oki Eiji35
Recruiting
Not Applicable
A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim* System for the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System study)Overactive bladderfrequent need to urinate10004994NL-OMON55598BlueWind Medical Ltd.25